Metaplastic breast cancer: clinicopathological features and its prognosis

Authors:

Abstract
Aims The prognosis of metaplastic breast cancer (MBC) is reportedly worse than that of triple-negative invasive ductal carcinoma (TN-IDC), but the determinants of poor prognosis are not yet known. Methods Patients from two Korean cancer centres were included in this study (67 MBC and 520 TN-IDC). Characteristics of the two disease groups, including clinical parameters, histological features, chemoresponsiveness, disease recurrence and survival estimates, were evaluated. Results MBC presented with larger tumours, more frequent distant metastasis and higher histological grade compared with TN-IDC (pConclusions MBC had worse survival outcomes compared with TN-IDC. Poor prognosis for MBC was likely caused by frequent recurrence with high initial stage and the unique biology of MBC itself.

This publication has 24 references indexed in Scilit: